Mark Geyer, MD
Physician, Clinical Fellow in Hematology and Oncology
Last active: 14 days ago
As of July 2014, I am a Clinical Fellow in hematology and medical oncology at Memorial Sloan-Kettering Cancer Center in New York City. I formerly served from 2011-2014 in the Department of Medicine at Massachusetts General Hospital and as a Clinical Fellow in Medicine at Harvard Medical School, and am board certified in internal medicine by the ABIM.
My clinical interests include caring for patients with a wide range of malignant and non-malignant hematological conditions, prevention and management of infectious diseases in the immunocompromised, and coordination of care in high-risk medically and socially complex patient populations. My research interests include improving outcomes in allogeneic stem cell transplantation for malignant and non-malignant diseases, particularly with alternative donor sources, and management of high-risk leukemias and sickle cell disease in young adults.
My active areas of clinical investigation include leukemia and stem cell transplantation. In addition to coordinating and serving as a co-investigator on several single-center and multi-center clinical trials, I have additional training in epidemiology and biostatistics, and have been involved in clinical data analysis and manuscript writing at all phases of projects. Additionally, I have significant laboratory experience working in the basic sciences, particularly in molecular and cellular immunology. I have extensive experience in medical writing and have served as principal or co-author on over a dozen articles published in leading medical and scientific journals, including Nature and the British Journal of Haematology
See my author profile on SCOPUS: http://www.scopus.com/authid/detail.url?authorId=43561336800
More recently, I have accepted part-time consulting projects requiring a trained US physician with scientific literacy and an ability to understand and interpret cutting-edge research in laboratory, translational, and clinical settings.